Bioneovan

Established in 2005, is a Chinese company specializing in the manufacturing of in vitro diagnostic reagents. The company focuses on the research, development, and production of diagnostic kits for infectious diseases such as hepatitis, norovirus, and parvovirus. Their product offerings include rapid test cassettes and ELISA kits. Operating from a 4,000-square-meter facility in Beijing, China, Bioneovan's mission is to improve global healthcare by providing reliable, innovative, and accessible diagnostic solutions to support the early detection and management of infectious diseases.

Bioneovan is a leading manufacturer of in vitro diagnostic reagents, specializing in clinical testing for infectious diseases such as Hepatitis, Norovirus, and Parvovirus. Our product range includes rapid test cassettes and ELISA kits. Located in Beijing, China, with a 4,000-square-meter workshop, we prioritize strict quality control and excellent customer service. In 2019, we upgraded our production capabilities by introducing automated equipment to improve efficiency and quality. All our products are registered with the National Medical Products Administration of China, and in 2020, we received ISO 13485:2016 certification for medical devices. We also developed and received regulatory approval for COVID-19 testing kits, including IgM/IgG antibody and antigen tests, which are now distributed globally.